NEWS & EVENTS

 

Microbiotica Wins Biotech and Money’s ‘Life Science Spin-out of the Year’

 
Microbiotica Wins Biotech and Money’s ‘Life Science Spin-out of the Year’

02 October 2017

Our client, Microbiotica, a Wellcome Trust Sanger Institute spin-out, won the title of UK Life Science Spin-out of the Year at the recent Biotech and Money 2017 Awards.

Microbiotica is a leading player in microbiome -based therapeutics. The company identifies gut bacteria linked to phenotype with unprecedented precision in order to discover and develop live bacterial therapeutics and biomarkers.

Read the full press release here.

Mewburn Partners Tanis Keirstead and Emily Hayes work with Microbiotica on their IP portfolio.